Biogen: Truist Securities raises to Buy from Hold; raises target price to $235 from $190
BIIB•Related News
Intel to upgrade, expand Irish manufacturing hub with $5.7 bln investment
INTC•
Apollomics regains Nasdaq compliance with $35 million market value requirement
APLM•
China aims to spur consumption in first five-year blueprint
MCHI•
Gloo Holdings announces availability of press release on public offering closing
GLOO•
MKS schedules Q2 2026 earnings release, conference call
MKSI•